Terms: = Brain cancer AND CTLA4, ALPS5, CD, CD152, CELIAC3, CTLA-4, GRD4, GSE, IDDM12 AND Diagnosis
167 results:
1. [Expression of immune checkpoints PD-L1, ctla4, LAG3 in the microenvironment of colon adenocarcinoma depending on MMR status].
Naumov SS; Krakhmal NV; Tashireva LA; Vtorushin SV
Arkh Patol; 2024; 86(2):6-13. PubMed ID: 38591901
[TBL] [Abstract] [Full Text] [Related]
2. [
Pruis IJ; Verburg FA; Balvers RK; Harteveld AA; Feelders RA; Vernooij MW; Smits M; Neggers SJCMM; Veldhuijzen van Zanten SEM
J Nucl Med; 2024 May; 65(5):688-692. PubMed ID: 38514085
[TBL] [Abstract] [Full Text] [Related]
3. Concentrations of S100B and neurofilament light chain in blood as biomarkers for checkpoint inhibitor-induced CNS inflammation.
Bjursten S; Zhao Z; Al Remawi H; Studahl M; Pandita A; Simrén J; Zetterberg H; Lundell AC; Rudin A; Ny L; Levin M
EBioMedicine; 2024 Feb; 100():104955. PubMed ID: 38171113
[TBL] [Abstract] [Full Text] [Related]
4. Analysis of Histomorphologic/Molecular Association and Immune Checkpoint Regulators in Epithelioid Glioblastoma and Pleomorphic Xanthoastrocytoma: Are These Tumors Potential Candidates for Immune Checkpoint Blockade?
Mahajan S; Singh J; Dandapath I; Jha P; Chaturvedi S; Ahuja A; Bhardwaj M; Saran R; Garg A; Sharma MC; Manjunath N; Suri A; Sarkar C; Suri V
Appl Immunohistochem Mol Morphol; 2024 Feb; 32(2):84-95. PubMed ID: 38158760
[TBL] [Abstract] [Full Text] [Related]
5. Imaging for assessment of cancer treatment response to immune checkpoint inhibitors can be complementary in identifying hypophysitis.
Galligan A; Iravani A; Lasocki A; Wallace R; Weppler AM; Sachithanandan N; Chiang C; Colman PG; Wentworth J; Spain L; Au-Yeung G; Lee B; Kay TWH; Hicks RJ; Sandhu S; Krishnamurthy B
Front Endocrinol (Lausanne); 2023; 14():1295865. PubMed ID: 38093958
[TBL] [Abstract] [Full Text] [Related]
6. Bilateral inferior petrosal sinus sampling: validity, diagnostic accuracy in lateralization of pituitary microadenoma, and treatment in eleven patients with Cushing's syndrome - a single-center retrospective cohort study.
Ardakani MT; Rabizadeh S; Yadegar A; Mohammadi F; Reyhan SK; Qahremani R; Ghanaati H; Esteghamati A; Nakhjavani M
BMC Endocr Disord; 2023 Oct; 23(1):232. PubMed ID: 37872539
[TBL] [Abstract] [Full Text] [Related]
7. Clinical features, diagnosis and treatment outcomes of Cushing's disease in children: A multicenter study.
Tarçın G; Çatlı G; Çetinkaya S; Eren E; Kardelen AD; Akıncı A; Böber E; Kara C; Yıldırım R; Er E; Polat R; Özhan B; Yıldız M; Kor Y; Evliyaoğlu O; Dündar B; Ercan O
Clin Endocrinol (Oxf); 2024 Jan; 100(1):19-28. PubMed ID: 37814958
[TBL] [Abstract] [Full Text] [Related]
8. Liquid Biopsy in Low-Grade Glioma: A Systematic Review and a Proposal for a Clinical Utility Score.
Zanin L; Sachkova A; Panciani PP; Rohde V; Fontanella MM; Schatlo B
Cell Mol Neurobiol; 2023 Nov; 43(8):3833-3845. PubMed ID: 37704931
[TBL] [Abstract] [Full Text] [Related]
9. Dexamethasone suppression for
Kim K; Kim DK; Moon JH; Kim EH; Kim SH; Ku CR; Lee EJ
Cancer Imaging; 2023 Sep; 23(1):85. PubMed ID: 37700359
[TBL] [Abstract] [Full Text] [Related]
10. Overcoming the immune suppressive nature of glioblastoma by leveraging the surgical intervention - current status and future perspectives.
Duerinck J; Tuyaerts S; Movahedi K; Neyns B
Front Immunol; 2023; 14():1183641. PubMed ID: 37275902
[TBL] [Abstract] [Full Text] [Related]
11. brain metastasis and survival outcomes after first-line therapy in metastatic melanoma: a multicenter DeCOG study on 1704 patients from the prospective skin cancer registry ADOREG.
Franklin C; Mohr P; Bluhm L; Meier F; Garzarolli M; Weichenthal M; Kähler K; Grimmelmann I; Gutzmer R; Utikal J; Terheyden P; Herbst R; Haferkamp S; Pfoehler C; Forschner A; Leiter U; Ziller F; Meiss F; Ulrich J; Kreuter A; Gebhardt C; Welzel J; Schilling B; Kaatz M; Scharfetter-Kochanek K; Dippel E; Nashan D; Sachse M; Weishaupt C; Löffler H; Gambichler T; Loquai C; Heinzerling L; Grabbe S; Debus D; Schley G; Hassel JC; Weyandt G; Trommer M; Lodde G; Placke JM; Zimmer L; Livingstone E; Becker JC; Horn S; Schadendorf D; Ugurel S
J Immunother Cancer; 2023 Apr; 11(4):. PubMed ID: 37028819
[TBL] [Abstract] [Full Text] [Related]
12. Autoantibody profiles in patients with immune checkpoint inhibitor-induced neurological immune related adverse events.
Müller-Jensen L; Knauss S; Ginesta Roque L; Schinke C; Maierhof SK; Bartels F; Finke C; Rentzsch K; Ulrich C; Mohr R; Stenzel W; Endres M; Boehmerle W; Huehnchen P
Front Immunol; 2023; 14():1108116. PubMed ID: 36845122
[TBL] [Abstract] [Full Text] [Related]
13. Comparison of the preoperative diagnostic accuracy of BIPSS versus MRI for Cushing disease: a single-centre experience.
Mao JN; Yan HY; Chen JY; Yan CL; Li P; Jin W; Hang CH
BMC Endocr Disord; 2023 Feb; 23(1):42. PubMed ID: 36793008
[TBL] [Abstract] [Full Text] [Related]
14. Pediatric Cushing's disease: Case reports and retrospective review.
Pomahacova R; Paterova P; Nykodymova E; Sykora J; Krsek M
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2024 Mar; 168(1):85-91. PubMed ID: 36504094
[TBL] [Abstract] [Full Text] [Related]
15. Corticotroph cell hyperplasia as a rare cause of ACTH-dependent Cushing syndrome.
Ferri J; Martínez-Ibañez J; Terradez L; Savall E; Martínez-Hervás S; Oller MC; Lorente R; Ascaso JF; Real JT
Endocrinol Diabetes Nutr (Engl Ed); 2022 Nov; 69(9):694-701. PubMed ID: 36470644
[TBL] [Abstract] [Full Text] [Related]
16. Usefulness of intraoperative rapid immunohistochemistry in the surgical treatment of brain tumors.
Inoue A; Watanabe H; Kondo T; Katayama E; Miyazaki Y; Suehiro S; Yamashita D; Taniwaki M; Kurata M; Shigekawa S; Kitazawa R; Kunieda T
Neuropathology; 2023 Jun; 43(3):209-220. PubMed ID: 36128673
[TBL] [Abstract] [Full Text] [Related]
17. Deficient mismatch repair/microsatellite unstable colorectal cancer: diagnosis, prognosis and treatment.
Taieb J; Svrcek M; Cohen R; Basile D; Tougeron D; Phelip JM
Eur J Cancer; 2022 Nov; 175():136-157. PubMed ID: 36115290
[TBL] [Abstract] [Full Text] [Related]
18. Central venous sampling and magnetic resonance imaging in the diagnosis of ACTH-dependent Cushing's syndrome.
Aydoğan Ünsal Y; Öz Gül Ö; Ateş C; Aydemir E; Cander S; Ersoy C; Özpar R; Hakyemez B; Ertürk E
Neuroradiol J; 2023 Jun; 36(3):341-345. PubMed ID: 36074996
[TBL] [Abstract] [Full Text] [Related]
19. Cushing's disease: adrenal steroidogenesis inhibitors.
Pivonello R; Simeoli C; Di Paola N; Colao A
Pituitary; 2022 Oct; 25(5):726-732. PubMed ID: 36036308
[TBL] [Abstract] [Full Text] [Related]
20. Pregnancy after pituitary surgery does not influence the recurrence of Cushing's disease.
Lousada LM; Tapia MJB; Cescato VAS; da Silva GO; Musolino NRC; Fragoso MCBV; Bronstein MD; Machado MC
Endocrine; 2022 Dec; 78(3):552-558. PubMed ID: 35930216
[TBL] [Abstract] [Full Text] [Related]
[Next]
